Kelonia Therapeutics only started human testing of its in vivo CAR-T therapy for multiple myeloma in August, but already has ...

Prenuvo CEO Andrew Lacy sat down with pharmaphorum after their Frontiers Health keynote to discuss: ...

Anti-APRIL antibody Voyxact (sibeprenlimab) has been approved by the US regulator to reduce proteinuria in adults with ...

The Centers for Medicare and Medicaid Services (CMS) has revealed the prices for the second batch of 15 drugs going through ...

This video captures the essence of a very special 10th Anniversary Frontiers Health - visionary talks, groundbreaking ...

When applied responsibly, AI empowers medical, commercial, and access teams to make faster, evidence-based decisions and ...

Digital health is now an essential tool to scaling healthcare, but there are still many challenges to deploying it scalably ...

Novo Nordisk said it will now move ahead with a phase 3 programme for both versions of the drug in adults with type 2 ...

At Frontiers Health 2025, we spoke with Meri Beckwith (Lindus Health), Daniel Diezi (Gerresheimer), and David Benshoof Klein ...

Reimbursement authority NICE has ruled that London-based Autolus' Aucatzyl (obecabtagene autoleucel or obe-cel) can be used ...

In a boost for the UK life sciences sector, a new life sciences hub located at Barts Health NHS Trust in London has opened ...

Dual glucagon (GCG) and GLP-1 agonist mazdutide is already approved for both type 2 diabetes and obesity in China at doses ...